A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis

BACKGROUND: Patients with ankylosing spondylitis (AS) are at increased risk of developing inflammatory bowel disease (IBD). We aimed to determine the variation in fecal calprotectin in AS over 5 years in relation to disease activity and medication and also to study the incidence of and predictors fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Klingberg, Eva, Strid, Hans, Ståhl, Arne, Deminger, Anna, Carlsten, Hans, Öhman, Lena, Forsblad-d’Elia, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289027/
https://www.ncbi.nlm.nih.gov/pubmed/28148281
http://dx.doi.org/10.1186/s13075-017-1223-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289027/
https://www.ncbi.nlm.nih.gov/pubmed/28148281
http://dx.doi.org/10.1186/s13075-017-1223-2

Ejemplares similares